Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HG146 in Recurrent or Metastatic Adenoid Cystic Carcinoma
NCT06781567Phase 2Recruiting
- Sponsor
- HitGen
- Start
- Dec 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HG146 in adenoid cystic carcinoma (ACC), sponsored by HitGen. Started Dec 2024; status: recruiting.
02
Drugs
HG146
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT06781567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06781567.